ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2446

DNA Methylation Profiles That Distinguish Rheumatoid Arthritis from Osteoarthritis in Fibroblast-like Synoviocytes Can be Detected in Immune Cells from Peripheral Blood

Brooke Rhead1, Calliope Holingue2, Michael Cole2, Xiaorong Shao2, Hong L. Quach3, Diana Quach3, Lisa F. Barcellos3 and Lindsey A. Criswell4, 1Genetic Epidemiology and Genomics Laboratory, Division of Epidemiology, University of California, Berkeley, Berkeley, CA, 2Genetic Epidemiology and Genomics Lab, Division of Epidemiology, University of California, Berkeley, Berkeley, CA, 3Epidemiology, University of California, Berkeley, Berkeley, CA, 4Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: DNA Methylation and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Rheumatoid arthritis (RA) is a chronic inflammatory disease with potential to cause substantial disability, primarily due to the erosive and deforming process in joints. RA etiology is complex, with contributions from genetic and non-genetic factors. Epigenetic changes, such as altered patterns of DNA methylation, are also present in RA. Recent work by Firestein and colleagues (Nakano, 2013) compared genome-wide DNA methylation profiles in synovium-derived fibroblast-like synoviocytes (FLS) from RA patients and osteoarthritis controls and identified a set of differentially methylated genes that appear to distinguish these two forms of arthritis. Given the greater accessibility of peripheral blood compared to synovium-derived FLS, we set out to determine whether similar methylome signatures were present in immune cell subsets in peripheral blood.

Methods:  We generated over 400 genome-wide DNA methylation profiles for 101 women (70 cases and 31 controls) using Illumina HumanMethylation450 BeadChips. Four FACS-sorted immune cell types were assayed for each individual: CD14+ monocytes, CD19+ B cells, CD4+ memory T cells, and CD4+ naive T cells. All samples were background subtracted using the lumi Bioconductor package and normalized using all sample mean normalization (ASMN) followed by beta-mixture quantile normalization (BMIQ). All study individuals were fully characterized for whole genome SNP profiles using the Illumina OmniExpress BeadChip. We excluded CpG sites near SNPs known to be common (>1%) from analysis, as well as sites with a low detection p-value, leaving 367,704 sites for analysis.

Results:  We examined the top differentially hypo- and hypermethylated (n = 17 and 18, respectively) loci from the Firestein study in each immune cell type and found strong evidence for overlapping RA methylome signatures between FLS and immune cells. The most significantly differentially methylated genes in cases vs. controls include STK24, ADAMTS2, CABLES1, CD55, COL4A1, COL4A2, CYFIP1, FOXO1, ITGB8, ITGBL1, MAP3K1, PHLPP1, PTPN14, RXRA, TGFBR2, and TIMP2. The strongest evidence for replication of differential methylation in candidate gene regions was observed for naive CD4+ T cells; more than 20% of CpG sites tested were hypermethylated in cases compared to controls.

Conclusion:  Methylation patterns that distinguish RA cases from controls in FLS are also present in immune cells from peripheral blood.  Our investigation of DNA methylation underscores the importance of epigenetic mechanisms in RA pathogenesis and represents the largest study, to date, of methylome profiles derived from immune cells.


Disclosure:

B. Rhead,
None;

C. Holingue,
None;

M. Cole,
None;

X. Shao,
None;

H. L. Quach,
None;

D. Quach,
None;

L. F. Barcellos,
None;

L. A. Criswell,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dna-methylation-profiles-that-distinguish-rheumatoid-arthritis-from-osteoarthritis-in-fibroblast-like-synoviocytes-can-be-detected-in-immune-cells-from-peripheral-blood/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology